Associate Professor, Medicine, University of Minnesota Medical School
Infectious Disease
Dr. Paul R. Bohjanen, MD
|
|
Give Review
Doctor Paul R. Bohjanen, MD practices Infectious Disease. He went to University of Michigan Medical School. Dr. Paul R. Bohjanen is also a published MD. He has 50 publication published. The most recent publication is: Human immunodeficiency virus type I as a target for gene therapy. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Fatty liver in Hispanics with HIV.
- Erratum for Rattenbacher et al., Analysis of CUGBP1 Targets Identifies GU-Repeat Sequences That Mediate Rapid mRNA Decay.
- Regulatory T Cell Induction and Retention in the Lungs Drives Suppression of Detrimental Type 2 Th Cells During Pulmonary Cryptococcal Infection.
- Seroprevalence of histoplasmosis in Kampala, Uganda.
- Chitin Recognition via Chitotriosidase Promotes Pathologic Type-2 Helper T Cell Responses to Cryptococcal Infection.
- Cellular Immune Activation in Cerebrospinal Fluid from Ugandans with Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome.
- Alternative polyadenylation regulates CELF1/CUGBP1 target transcripts following T cell activation.
- Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
- Post-Transcriptional Regulation of Cytokine Signaling by AU-Rich and GU-Rich Elements.
- CELFish ways to modulate mRNA decay.
- Perspectives on the ARE as it turns 25 years old.
- Evaluating posttranscriptional regulation of cytokine genes.
- Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T Cell activation.
- Global assessment of GU-rich regulatory content and function in the human transcriptome.
- Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1.
- Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa.
- Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.
- Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV th...
- Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay.
- Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.
- Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory.
- Tristetraprolin mediates interferon-gamma mRNA decay.
- Posttranscriptional regulation of gene networks by GU-rich elements and CELF proteins.
- Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy.
- Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.
- Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1.
- Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome.
- Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
- Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.
- Reovirus induces and benefits from an integrated cellular stress response.
- Coordinate stabilization of growth-regulatory transcripts in T cell malignancies.
- Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.
- Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation.
- Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis.
- AU RNA-binding factors differ in their binding specificities and affinities.
- cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
- An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA.
- Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines.
- DNA fragments of altered electrophoretic mobility in leukemia samples can arise from double-strand DNA breaks at nuclease hypersensitive sites of active genes.
- A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.
- TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation.
- Human immunodeficiency virus type I as a target for gene therapy.
- HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities.
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.
- Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
- Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.
- Microarray-based analyses of mRNA decay in the regulation of mammalian gene expression.
- Global assessment of cross-hybridization for oligonucleotide arrays.
- A case for treating high hepatitis B DNA levels before starting HIV therapy.
Schools
University of Mi Med Sch
Duke University
Duke University Mc
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- Choice Plus POS
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Duke University Hospital -
University of Michigan Medical School
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1235175449 | |
| NPPES Provider LastName | BOHJANEN | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 55455 | |
| NPPES Provider State | MN | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 490.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235175449 |
| Last Name Of The Provider | BOHJANEN |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Elliot L. Francke, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christian G. Schrock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason V. Baker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald L. Schut, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas S. Vogenthaler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kent B. Crossley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime S. Green, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory A. Filice, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexa A. Pragman, MD
This Doctor is OpenDoctor Recommended.
|